Nab-paclitaxel plus cisplatin versus gemcitabine plus cisplatin as first-line treatment in advanced biliary tract cancer: results of a multicentre, randomised, phase II trial.
Saved in:
| Title: | Nab-paclitaxel plus cisplatin versus gemcitabine plus cisplatin as first-line treatment in advanced biliary tract cancer: results of a multicentre, randomised, phase II trial. |
|---|---|
| Authors: | Yang, Xiao1 (AUTHOR), Dai, Yu-Hong1 (AUTHOR), Peng, Hui1 (AUTHOR), Zhang, Ming-Sheng1 (AUTHOR), Fu, Qiang1 (AUTHOR), Liu, Shun-Fang1 (AUTHOR), Sun, Li1 (AUTHOR), Zou, Yan-Mei1 (AUTHOR), Xu, Hai-Sheng2 (AUTHOR), Qiu, Ping3 (AUTHOR), Qiu, Hong1 (AUTHOR), Huang, Qiao4 (AUTHOR), Cheng, Heng-hui1 (AUTHOR) hhcheng2007@hust.edu.cn, Zhuang, Liang1 (AUTHOR) mrzhuangliang@126.com |
| Source: | BMC Cancer. 8/16/2025, Vol. 25 Issue 1, p1-14. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14712407 |
|---|---|
| DOI: | 10.1186/s12885-025-14581-3 |
